AI-Assisted CT as a Clinical and Research Tool for COVID-19

There is compelling support for widening the role of computed tomography (CT) COVID-19 in clinical and research scenarios. Reverse transcription polymerase chain reaction (RT-PCR) testing, gold standard diagnosis, has two potential weaknesses: delay obtaining results possibility RT-PCR test kits running out when demand spikes or being unavailable altogether. This perspective article discusses use CT conjunction with hospitals lacking sufficient access to kits. The precedent this approach discussed based on diagnosis screening United Kingdom China. hurdles challenges are presented, which need addressing prior realization roles artificial intelligence (AI). include a more accurate classification, characterization mechanisms, informing trial response criteria as surrogate outcomes.